ASPI vs PATH · rev $4.1M vs P/E 19, rev $1.61B
ASP Isotopes Inc. Common Stock (ASPI) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
ASP Isotopes Inc. Common Stock (ASPI) is a chemicals company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ASPI revenue for 2024-12-31 was $4.1M. Net income was -$32.4M. Revenue was up 857.0% from 2023-12-31 to 2024-12-31. ASPI currently screens at market cap $620.7M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ASPI currently screens at market cap $620.7M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ASPI and PATH stock pages for the full models.
Not investment advice.